SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-19-000111
Filing Date
2019-02-08
Accepted
2019-02-08 10:48:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 14, 2019 inflarx13ga-021419.htm SC 13G/A 98573
2 JOINT FILING AGREEMENT inflarxex991-021419.htm EX-99.1 8260
  Complete submission text file 0001013594-19-000111.txt   108329
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Subject) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90181 | Film No.: 19578478
SIC: 2834 Pharmaceutical Preparations

Mailing Address GORKISTRASSE 9 ERFUT 2M 99084
Business Address GORKISTRASSE 9 ERFUT 2M 99084 49 (0) 361 7447 601
Private Equity Thuringen GmbH & Co (Filed by) CIK: 0001730223 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13G/A